Abstract P5-07-08: Evaluating the risk of cardiotoxicity associated with concurrent trastuzumab emtansine (TDM1) and radiation therapy in patients with early-stage HER2 positive breast cancer

Authors

Dillon Cason MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

3-2023

Volume

83

Issue

5

Published In/Presented At

https://doi.org/10.1158/1538-7445.SABCS22-P5-07-08

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine

Document Type

Article